Dr. Silva Boyajian, MD, MS

Dr. Boyajian practices at Adventist Health Glendale in Glendale, California, part of Adventist Health.

Dr. Boyajian's NPI, 1538513056, was assigned on April 21, 2016. Dr. Boyajian graduated from Creighton University School of Medicine - Omaha in 2016. Dr. Boyajian holds California license A150387.

Dr. Boyajian's primary practice is Adventist Health Glendale, at 1509 E Wilson Terrace, Glendale, CA 91206 in Los Angeles County. The practice phone is (818) 409-8202.

Dr. Boyajian's primary practice is Adventist Health Glendale in Glendale, California, part of Adventist Health. Dr. Boyajian is also affiliated with Huntington Hospital. The medical group on file is Facey Medical Group. Dmand AI also links Dr. Boyajian to 1 more hospital and 5 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boyajian practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Boyajian's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Boyajian is board certified in emergency medicine by the American Board of Emergency Medicine. Dr. Boyajian is licensed in California.

CMS data shows 518 Medicare services from Dr. Boyajian across 5 procedure codes in 2024, for 484 Medicare patients. Medicare paid $60,624 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 484 Medicare patients who saw Dr. Boyajian in 2024. The largest group is 65 to 74, with 168 patients. 75% of them have arthritis, and 75% have high blood pressure. 73% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Boyajian's median patient age at 58, with 55% women.

In 2024, Dr. Boyajian wrote 62 Medicare Part D claims for 49 patients. 100% of them were for generic drugs. CMS names the drug for 26 of them, across 1 drug with 11 or more claims each, at $153 in total drug cost. In 2023, CMS named 28 claims across 1 drug.

Dr. Boyajian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Boyajian in 2018. 2018 was the busiest year, with 2. Dr. Boyajian's most frequent co-authors are Jagdipak S. Heer, MD, Timothy C. Lin, DO and Daniel Quesada, MD.

CMS Open Payments shows 5 general payments to Dr. Boyajian from 4 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. iRhythm Technologies, Inc. paid the most, $37.

Dr. Boyajian graduated from Creighton University School of Medicine - Omaha in 2016.

Dr. Boyajian is in network with 12 carriers, including United Healthcare, Elevance and Aetna. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.